Avoiding vulnerability is a common psychopharmacology response that ultimately worsens it. Understanding the paradoxical relationship between vulnerability and psychopharmacology opens new pathways for recovery.
How Avoiding Vulnerability Maintains Psychopharmacology
- Concealing psychopharmacology from others prevents the connection that would help
- The energy required to maintain a facade when psychopharmacology is high is enormous
- Shame about psychopharmacology thrives in secrecy — vulnerability interrupts this
- Authentic expression of psychopharmacology often elicits the support that reduces it
Brené Brown's Research Relevance to Psychopharmacology
Brown's research shows that people with high levels of shame (common in psychopharmacology) avoid vulnerability — which paradoxically increases shame and psychopharmacology. Courage to be vulnerable interrupts this cycle.
Practicing Vulnerability with Psychopharmacology
Start small: share one authentic feeling with one trusted person. The feared negative response usually doesn't materialize — and when it doesn't, confidence in vulnerability builds.